• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For March 3, 2022

    3/3/22 4:46:21 AM ET
    $ABUS
    $ACR
    $ADCT
    $ADTH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate Investment Trusts
    Real Estate
    Get the next $ABUS alert in real time by email

     

    Companies Reporting Before The Bell

    • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million.

    • Urban One (NASDAQ:UONEK) is likely to report earnings for its fourth quarter.

    • Tile Shop Holdings (NASDAQ:TTSH) is likely to report earnings for its fourth quarter.

    • Oxford Square Capital (NASDAQ:OXSQ) is estimated to report quarterly earnings at $0.09 per share on revenue of $10.30 million.

    • Aurora Mobile (NASDAQ:JG) is projected to report quarterly loss at $0.07 per share on revenue of $15.65 million.

    • Mobile TeleSystems (NYSE:MBT) is estimated to report quarterly earnings at $0.19 per share on revenue of $1.69 billion.

    • LENSAR (NASDAQ:LNSR) is estimated to report quarterly loss at $0.52 per share on revenue of $8.70 million.

    • Bluegreen Vacations (NYSE:BVH) is likely to report quarterly earnings at $0.62 per share on revenue of $203.89 million.

    • Fulcrum Therapeutics (NASDAQ:FULC) is projected to report quarterly loss at $0.73 per share on revenue of $2.68 million.

    • EyePoint Pharmaceuticals (NASDAQ:EYPT) is expected to report quarterly loss at $0.53 per share on revenue of $9.80 million.

    • Passage Bio (NASDAQ:PASG) is estimated to report earnings for its fourth quarter.

    • Boqii Holding (NYSE:BQ) is projected to report quarterly loss at $0.09 per share on revenue of $59.45 million.

    • GlycoMimetics (NASDAQ:GLYC) is estimated to report earnings for its fourth quarter.

    • MINISO Group Holding (NYSE:MNSO) is likely to report quarterly earnings at $0.08 per share on revenue of $422.86 million.

    • Crescent Point Energy (NYSE:CPG) is expected to report quarterly earnings at $0.22 per share on revenue of $666.90 million.

    • Revlon (NYSE:REV) is likely to report quarterly earnings at $0.06 per share on revenue of $645.60 million.

    • Toro (NYSE:TTC) is estimated to report quarterly earnings at $0.62 per share on revenue of $967.83 million.

    • Antares Pharma (NASDAQ:ATRS) is projected to report quarterly earnings at $0.01 per share on revenue of $46.69 million.

    • Concert Pharmaceuticals (NASDAQ:CNCE) is projected to report quarterly loss at $0.73 per share on revenue of $20.00 thousand.

    • Weibo (NASDAQ:WB) is likely to report quarterly earnings at $0.81 per share on revenue of $607.75 million.

    • Burlington Stores (NYSE:BURL) is expected to report quarterly earnings at $3.25 per share on revenue of $2.78 billion.

    • BJ's Wholesale Club (NYSE:BJ) is likely to report quarterly earnings at $0.74 per share on revenue of $4.38 billion.

    • argenx (NASDAQ:ARGX) is expected to report quarterly loss at $4.82 per share on revenue of $18.07 million.

    • Toronto-Dominion Bank (NYSE:TD) is projected to report quarterly earnings at $1.62 per share on revenue of $8.56 billion.

    • Best Buy Co (NYSE:BBY) is projected to report quarterly earnings at $2.73 per share on revenue of $16.59 billion.

    • Bilibili (NASDAQ:BILI) is projected to report quarterly loss at $0.68 per share on revenue of $913.86 million.

    • Kroger (NYSE:KR) is expected to report quarterly earnings at $0.74 per share on revenue of $32.86 billion.

    • Canadian Natural Res (NYSE:CNQ) is projected to report quarterly earnings at $1.65 per share on revenue of $6.82 billion.

    • Rain Therapeutics (NASDAQ:RAIN) is likely to report earnings for its fourth quarter.

    • HUTCHMED (China) (NASDAQ:HCM) is estimated to report earnings for its fourth quarter.

    • Fusion Fuel Green (NASDAQ:HTOO) is estimated to report earnings for its fourth quarter.

    • Via Renewables (NASDAQ:VIA) is likely to report earnings for its fourth quarter.

    • REE Automotive (NASDAQ:REE) is expected to report quarterly loss at $0.12 per share on revenue of $360.00 thousand.

    • Holley (NYSE:HLLY) is projected to report quarterly earnings at $0.12 per share on revenue of $148.58 million.

    • Utz Brands (NYSE:UTZ) is estimated to report quarterly earnings at $0.15 per share on revenue of $296.81 million.

    • ADC Therapeutics (NYSE:ADCT) is expected to report quarterly loss at $0.86 per share on revenue of $16.46 million.

    • Materialise (NASDAQ:MTLS) is estimated to report quarterly earnings at $0.04 per share on revenue of $59.74 million.

    • WAVE Life Sciences (NASDAQ:WVE) is likely to report quarterly loss at $0.51 per share on revenue of $15.79 million.

    • Sotherly Hotels (NASDAQ:SOHO) is estimated to report quarterly loss at $0.39 per share on revenue of $33.25 million.

    • Marcus (NYSE:MCS) is estimated to report quarterly loss at $0.18 per share on revenue of $154.31 million.

    • Brown Forman Inc Class B Common Stock (NYSE:BF) is estimated to report quarterly earnings at $0.47 per share on revenue of $983.13 million.

    • WhiteHorse Finance (NASDAQ:WHF) is likely to report quarterly earnings at $0.37 per share on revenue of $19.27 million.

    • Tecnoglass (NASDAQ:TGLS) is estimated to report quarterly earnings at $0.41 per share on revenue of $129.36 million.

    • Verona Pharma (NASDAQ:VRNA) is estimated to report earnings for its fourth quarter.

    • Stereotaxis (AMEX:STXS) is estimated to report quarterly loss at $0.05 per share on revenue of $7.73 million.

    • Methode Electronics (NYSE:MEI) is expected to report quarterly earnings at $0.72 per share on revenue of $281.60 million.

    • Altisource Portfolio (NASDAQ:ASPS) is projected to report quarterly loss at $0.77 per share on revenue of $39.56 million.

    • Gogo (NASDAQ:GOGO) is projected to report quarterly earnings at $0.08 per share on revenue of $89.67 million.

    • Superior Industries Intl (NYSE:SUP) is expected to report quarterly loss at $0.22 per share on revenue of $338.50 million.

    • Sprague Resources (NYSE:SRLP) is likely to report quarterly earnings at $0.34 per share on revenue of $968.22 million.

    • GMS (NYSE:GMS) is likely to report quarterly earnings at $1.74 per share on revenue of $1.13 billion.

    • CRA International (NASDAQ:CRAI) is expected to report quarterly earnings at $1.05 per share on revenue of $138.04 million.

    • Arbutus Biopharma (NASDAQ:ABUS) is likely to report quarterly loss at $0.19 per share on revenue of $2.87 million.

    • Big Lots (NYSE:BIG) is estimated to report quarterly earnings at $1.90 per share on revenue of $1.72 billion.

    • Titan Intl (NYSE:TWI) is expected to report quarterly earnings at $0.17 per share on revenue of $441.59 million.

    • Consolidated Comms Hldgs (NASDAQ:CNSL) is likely to report quarterly earnings at $0.04 per share on revenue of $318.84 million.

    • Brown Forman Inc Class A Common Stock (NYSE:BF) is likely to report earnings for its third quarter.

    • Canaan (NASDAQ:CAN) is expected to report earnings for its fourth quarter.

    • Sibanye Stillwater (NYSE:SBSW) is expected to report earnings for its Fiscal Year 2021.

    • Grab Hldgs (NASDAQ:GRAB) is estimated to report earnings for its fourth quarter.

     

    Companies Reporting After The Bell

    • Payoneer Global (NASDAQ:PAYO) is estimated to report quarterly loss at $0.02 per share on revenue of $126.29 million.

    • VIZIO Holding (NYSE:VZIO) is likely to report quarterly loss at $0.18 per share on revenue of $699.36 million.

    • Ooma (NYSE:OOMA) is expected to report quarterly earnings at $0.10 per share on revenue of $49.97 million.

    • CPS Technologies (NASDAQ:CPSH) is expected to report earnings for its fourth quarter.

    • AdTheorent Holding (NASDAQ:ADTH) is likely to report quarterly earnings at $0.02 per share on revenue of $50.81 million.

    • Vicarious Surgical (NYSE:RBOT) is estimated to report earnings for its fourth quarter.

    • EzFill Holdings (NASDAQ:EZFL) is likely to report quarterly loss at $0.10 per share on revenue of $2.00 million.

    • PowerSchool Holdings (NYSE:PWSC) is projected to report quarterly earnings at $0.09 per share on revenue of $141.69 million.

    • Duolingo (NASDAQ:DUOL) is expected to report quarterly loss at $0.68 per share on revenue of $68.88 million.

    • DBV Technologies (NASDAQ:DBVT) is estimated to report quarterly loss at $0.54 per share on revenue of $2.21 million.

    • Treace Medical Concepts (NASDAQ:TMCI) is estimated to report earnings for its fourth quarter.

    • Agilon Health (NYSE:AGL) is expected to report quarterly loss at $0.11 per share on revenue of $452.89 million.

    • Intl General Insurance (NASDAQ:IGIC) is expected to report quarterly earnings at $0.23 per share on revenue of $148.90 million.

    • Entravision Comms (NYSE:EVC) is estimated to report quarterly earnings at $0.15 per share on revenue of $226.40 million.

    • Banco BBVA Argentina (NYSE:BBAR) is likely to report quarterly earnings at $0.21 per share on revenue of $236.94 million.

    • Trinity Capital (NASDAQ:TRIN) is expected to report quarterly earnings at $0.41 per share on revenue of $22.18 million.

    • PerkinElmer (NYSE:PKI) is expected to report quarterly earnings at $0.22 per share on revenue of $5.58 billion.

    • Montrose Environmental Gr (NYSE:MEG) is estimated to report quarterly earnings at $0.33 per share on revenue of $1.18 billion.

    • Grid Dynamics Holdings (NASDAQ:GDYN) is likely to report quarterly earnings at $0.08 per share on revenue of $58.55 million.

    • Algonquin Power (NYSE:AQN) is expected to report quarterly earnings at $0.28 per share on revenue of $690.81 million.

    • Invesco DWA Industrials Momentum ETF (NASDAQ:PRN) is estimated to report quarterly loss at $0.42 per share on revenue of $3.25 million.

    • Atreca (NASDAQ:BCEL) is projected to report earnings for its fourth quarter.

    • Gossamer Bio (NASDAQ:GOSS) is likely to report earnings for its fourth quarter.

    • Puma Biotechnology (NASDAQ:PBYI) is likely to report quarterly loss at $0.09 per share on revenue of $47.17 million.

    • Fidus Investment (NASDAQ:FDUS) is expected to report quarterly earnings at $0.36 per share on revenue of $20.53 million.

    • Funko (NASDAQ:FNKO) is estimated to report quarterly earnings at $0.24 per share on revenue of $272.49 million.

    • AeroVironment (NASDAQ:AVAV) is expected to report quarterly earnings at $0.30 per share on revenue of $106.72 million.

    • Cellectis (NASDAQ:CLLS) is likely to report quarterly loss at $0.92 per share on revenue of $8.72 million.

    • Calyxt (NASDAQ:CLXT) is likely to report quarterly loss at $0.41 per share on revenue of $2.64 million.

    • Great Ajax (NYSE:AJX) is projected to report quarterly earnings at $0.38 per share on revenue of $20.51 million.

    • Gap (NYSE:GPS) is expected to report quarterly loss at $0.14 per share on revenue of $4.49 billion.

    • Costco Wholesale (NASDAQ:COST) is projected to report quarterly earnings at $2.73 per share on revenue of $51.37 billion.

    • SIGA Technologies (NASDAQ:SIGA) is estimated to report earnings for its fourth quarter.

    • Smith & Wesson Brands (NASDAQ:SWBI) is likely to report quarterly earnings at $0.86 per share on revenue of $198.29 million.

    • Sweetgreen (NYSE:SG) is likely to report quarterly loss at $0.66 per share on revenue of $84.71 million.

    • Cvent Holding (NASDAQ:CVT) is projected to report quarterly earnings at $0.02 per share on revenue of $140.72 million.

    • Arteris (NASDAQ:AIP) is estimated to report quarterly loss at $0.17 per share on revenue of $10.70 million.

    • Runway Growth Finance (NASDAQ:RWAY) is likely to report quarterly earnings at $0.26 per share on revenue of $18.12 million.

    • Xponential Fitness (NYSE:XPOF) is likely to report quarterly loss at $0.14 per share on revenue of $42.03 million.

    • Integral Ad Science (NASDAQ:IAS) is likely to report quarterly loss at $0.01 per share on revenue of $94.83 million.

    • Enovix (NASDAQ:ENVX) is estimated to report quarterly loss at $0.15 per share on revenue of $750.00 thousand.

    • Alignment Healthcare (NASDAQ:ALHC) is estimated to report quarterly loss at $0.30 per share on revenue of $269.57 million.

    • Evolus (NASDAQ:EOLS) is estimated to report quarterly loss at $0.19 per share on revenue of $33.99 million.

    • Chembio Diagnostics (NASDAQ:CEMI) is projected to report quarterly loss at $0.20 per share on revenue of $13.55 million.

    • National CineMedia (NASDAQ:NCMI) is projected to report quarterly loss at $0.04 per share on revenue of $67.80 million.

    • Oncolytics Biotech (NASDAQ:ONCY) is expected to report earnings for its fourth quarter.

    • Veritone (NASDAQ:VERI) is estimated to report quarterly earnings at $0.20 per share on revenue of $44.80 million.

    • Salem Media Group (NASDAQ:SALM) is projected to report quarterly earnings at $0.06 per share on revenue of $66.59 million.

    • Issuer Direct (AMEX:ISDR) is likely to report earnings for its fourth quarter.

    • INmune Bio (NASDAQ:INMB) is expected to report earnings for its fourth quarter.

    • First Eagle Alternative (NASDAQ:FCRD) is expected to report quarterly earnings at $0.10 per share on revenue of $8.43 million.

    • Eagle Bulk Shipping (NASDAQ:EGLE) is expected to report quarterly earnings at $6.00 per share on revenue of $152.12 million.

    • Crawford & Company Common Stock (NYSE:CRD) is estimated to report quarterly earnings at $0.18 per share on revenue of $277.96 million.

    • ACRES Commercial Realty (NYSE:ACR) is projected to report quarterly earnings at $0.14 per share on revenue of $11.90 million.

    • Profound Medical (NASDAQ:PROF) is projected to report quarterly loss at $0.37 per share on revenue of $3.00 million.

    • FedNat Holding (NASDAQ:FNHC) is projected to report quarterly loss at $1.02 per share on revenue of $69.59 million.

    • Aziyo Biologics (NASDAQ:AZYO) is expected to report quarterly loss at $0.68 per share on revenue of $11.06 million.

    • Elastic (NYSE:ESTC) is expected to report quarterly loss at $0.21 per share on revenue of $209.36 million.

    • Quanex Building Prods (NYSE:NX) is projected to report quarterly earnings at $0.26 per share on revenue of $242.89 million.

    • Crawford & Company Common Stock (NYSE:CRD) is estimated to report earnings for its fourth quarter.

    • Cooper Companies (NYSE:COO) is estimated to report quarterly earnings at $3.10 per share on revenue of $744.34 million.

    • Marvell Technology (NASDAQ:MRVL) is estimated to report quarterly earnings at $0.48 per share on revenue of $1.32 billion.

    • Broadcom (NASDAQ:AVGO) is likely to report quarterly earnings at $8.08 per share on revenue of $7.60 billion.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ABUS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABUS
    $ACR
    $ADCT
    $ADTH

    CompanyDatePrice TargetRatingAnalyst
    Elastic N.V.
    $ESTC
    4/23/2026$49.00Neutral
    Rothschild & Co Redburn
    Passage Bio Inc.
    $PASG
    4/21/2026Buy → Hold
    TD Cowen
    Elastic N.V.
    $ESTC
    4/21/2026$50.00Neutral
    Goldman
    Passage Bio Inc.
    $PASG
    4/21/2026$7.00Buy → Neutral
    Chardan Capital Markets
    Passage Bio Inc.
    $PASG
    4/21/2026$8.00Outperform → Neutral
    Wedbush
    Utz Brands Inc
    $UTZ
    4/20/2026$11.00 → $9.00Hold
    TD Cowen
    Alignment Healthcare Inc.
    $ALHC
    4/17/2026$24.00Outperform
    Wolfe Research
    Marvell Technology Inc.
    $MRVL
    4/16/2026$120.00 → $140.00Buy
    Stifel
    More analyst ratings

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Volpe John Paul bought $7,180 worth of shares (1,000 units at $7.18) (SEC Form 4)

    4 - WhiteHorse Finance, Inc. (0001552198) (Issuer)

    3/17/26 8:33:31 PM ET
    $WHF
    Finance Companies
    Finance

    Director Estes Ronald E. bought $11,328 worth of shares (800 units at $14.16), increasing direct ownership by 2% to 40,443 units (SEC Form 4)

    4 - Trinity Capital Inc. (0001786108) (Issuer)

    3/17/26 7:30:08 PM ET
    $TRIN
    Finance: Consumer Services
    Finance

    CEO, President and CIO Brown Kyle Steven covered exercise/tax liability with 16,187 shares, was granted 256,588 shares and bought $50,018 worth of shares (3,532 units at $14.16), increasing direct ownership by 65% to 620,709 units (SEC Form 4)

    4 - Trinity Capital Inc. (0001786108) (Issuer)

    3/17/26 7:30:05 PM ET
    $TRIN
    Finance: Consumer Services
    Finance

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rothschild & Co Redburn initiated coverage on Elastic with a new price target

    Rothschild & Co Redburn initiated coverage of Elastic with a rating of Neutral and set a new price target of $49.00

    4/23/26 7:55:51 AM ET
    $ESTC
    Computer Software: Prepackaged Software
    Technology

    Passage BIO downgraded by TD Cowen

    TD Cowen downgraded Passage BIO from Buy to Hold

    4/21/26 9:31:55 AM ET
    $PASG
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Goldman initiated coverage on Elastic with a new price target

    Goldman initiated coverage of Elastic with a rating of Neutral and set a new price target of $50.00

    4/21/26 7:32:58 AM ET
    $ESTC
    Computer Software: Prepackaged Software
    Technology

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 3 filed by new insider Xu Lili

    3/A - MINISO Group Holding Ltd (0001815846) (Issuer)

    4/24/26 8:10:01 AM ET
    $MNSO
    Department/Specialty Retail Stores
    Consumer Discretionary

    Director Samueli Henry was granted 864 shares, increasing direct ownership by 25% to 4,356 units (SEC Form 4)

    4 - Broadcom Inc. (0001730168) (Issuer)

    4/23/26 4:30:10 PM ET
    $AVGO
    Semiconductors
    Technology

    SEC Form 4 filed by You Harry L.

    4 - Broadcom Inc. (0001730168) (Issuer)

    4/22/26 4:58:53 PM ET
    $AVGO
    Semiconductors
    Technology

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Treace to Report First Quarter 2026 Financial Results on May 8, 2026

    PONTE VEDRA, Fla., April 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the first quarter 2026 before the start of trading on Friday, May 8, 2026. Company management will host a conference call to discuss financial results beginning at 8:00 am ET. Investors interested in listening to the conference call may do so by registering. Once registered, participants will receive dial-in numbers and a unique pin to join the call and ask questions. A live and ar

    4/24/26 7:05:00 AM ET
    $TMCI
    Medical/Dental Instruments
    Health Care

    Aurora Mobile's GPTBots.ai Integrates DeepSeek-V4 Preview, Bringing Million-Token Context and Next-Generation Agentic AI to Enterprise Users

    HONG KONG, April 24, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ:JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services, today announced that its enterprise-grade AI agent platform, GPTBots.ai, has integrated the newly released DeepSeek-V4 Preview series. This integration delivers immediate, production-ready access to one of the most capable open-source AI models available today—combining DeepSeek-V4's breakthrough long-context processing and frontier agentic performance with GPTBots.ai's enterprise-grade security, no-code deployment, and intelligent workflow orchestration. DeepSeek-V4: A New Frontier in Open-Source

    4/24/26 7:00:00 AM ET
    $JG
    Computer Software: Programming Data Processing
    Technology

    MINISO Announces Annual General Meeting on June 18, 2026 and Filing of Annual Report on Form 20-F

    GUANGZHOU, China, April 24, 2026 /PRNewswire/ -- MINISO Group Holding Limited (NYSE:MNSO, HKEX: 9896)) ("MINISO", "MINISO Group" or the "Company"), a global high-growth value retailer offering a variety of trendy lifestyle products featuring distinctive IP designs, today announced that it will hold an annual general meeting of the Company's shareholders (the "AGM") at 11:00 a.m. Beijing time on June 18, 2026 at Flats B-D, 35/F, Plaza 88, 88 Yeung Uk Road, Tsuen Wan, the New Territories, Hong Kong, for the purposes of considering and, if thought fit, passing each of the proposed resolutions set forth in the notice of the AGM (the "AGM Notice"). The AGM Notice, the ballot, the form of proxy an

    4/24/26 5:00:00 AM ET
    $MNSO
    Department/Specialty Retail Stores
    Consumer Discretionary

    $ABUS
    $ACR
    $ADCT
    $ADTH
    SEC Filings

    View All

    SEC Form 20-F filed by MINISO Group Holding Limited

    20-F - MINISO Group Holding Ltd (0001815846) (Filer)

    4/24/26 8:14:02 AM ET
    $MNSO
    Department/Specialty Retail Stores
    Consumer Discretionary

    SEC Form 6-K filed by MINISO Group Holding Limited

    6-K - MINISO Group Holding Ltd (0001815846) (Filer)

    4/24/26 8:00:28 AM ET
    $MNSO
    Department/Specialty Retail Stores
    Consumer Discretionary

    SEC Form SD filed by D/B/A Sibanye-Stillwater Limited

    SD - Sibanye Stillwater Ltd (0001786909) (Filer)

    4/24/26 7:01:22 AM ET
    $SBSW
    Precious Metals
    Basic Materials

    $ABUS
    $ACR
    $ADCT
    $ADTH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-5) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:04:01 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-4) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:03:14 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for TESTOSTERONE UNDECANOATE issued to ANTARES PHARMA INC

    Submission status for ANTARES PHARMA INC's drug TESTOSTERONE UNDECANOATE (ORIG-1) with active ingredient TESTOSTERONE UNDECANOATE has changed to 'Approval' on 03/28/2022. Application Category: NDA, Application Number: 208088, Application Classification: Type 3 - New Dosage Form

    3/30/22 12:07:58 PM ET
    $ATRS
    Medical/Dental Instruments
    Health Care

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Financials

    Live finance-specific insights

    View All

    Treace to Report First Quarter 2026 Financial Results on May 8, 2026

    PONTE VEDRA, Fla., April 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the first quarter 2026 before the start of trading on Friday, May 8, 2026. Company management will host a conference call to discuss financial results beginning at 8:00 am ET. Investors interested in listening to the conference call may do so by registering. Once registered, participants will receive dial-in numbers and a unique pin to join the call and ask questions. A live and ar

    4/24/26 7:05:00 AM ET
    $TMCI
    Medical/Dental Instruments
    Health Care

    WhiteHorse Finance, Inc. To Report First Quarter 2026 Financial Results

    NEW YORK, April 23, 2026 /PRNewswire/ -- WhiteHorse Finance, Inc. ("WhiteHorse Finance" or the "Company") (NASDAQ:WHF) today announced that it will release its first quarter financial results for the period ended March 31, 2026 on Thursday, May 7, 2026. The Company will discuss its financial results on a conference call that day at 2:00 p.m. ET. To access the teleconference, please dial 800-267-6316 (domestic) or +1 203-518-9766 (international) approximately 10 minutes before the teleconference's scheduled start time and reference ID #WHFQ126. Investors may also access the call on the investor relations portion of the Company's website at www.whitehorsefinance.com.If you are unable to access

    4/23/26 5:00:00 PM ET
    $WHF
    Finance Companies
    Finance

    Urban One, Inc. First Quarter 2026 Results Conference Call

    SILVER SPRING, Md., April 23, 2026 /PRNewswire/ -- Urban One, Inc. (NASDAQ:UONEK, UONE)) will be holding a conference call for investors, analysts and other interested parties to discuss its results for the first fiscal quarter of 2026. The conference call is scheduled for Thursday, May 14, 2026, at 10:00 a.m. EDT. To participate on this call, U.S. callers may dial toll-free +1-888-596-4144; international callers may dial direct +1-646-968-2525. The Access Code is 3438559.A replay of the conference call will be available from 2:00 p.m. EDT May 14, 2026, until 11:59 p.m. EDT May

    4/23/26 4:30:00 PM ET
    $UONE
    $UONEK
    Broadcasting
    Consumer Discretionary

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Leadership Updates

    Live Leadership Updates

    View All

    Quality Industrial Corp. Announces CEO Transition

    Carsten Kjems Falk Appointed Chief Executive Officer SAN FRANCISCO, CA, April 23, 2026 (GLOBE NEWSWIRE) -- Quality Industrial Corp. (the "Company") (OTCID: QIND), an industrial and energy-focused company providing comprehensive solutions for the liquefied petroleum gas ("LPG") industry, today announced the appointment of Carsten Kjems Falk as Chief Executive Officer. Mr. Falk will continue to serve as Chief Financial Officer and a director of the Company. The appointment follows the resignation of John-Paul Backwell as Chief Executive Officer, for personal and health reasons. Mr. Backwell will continue to serve as a director of the Company. Mr. Falk has served as the Company's Interim Ch

    4/23/26 8:00:00 AM ET
    $HTOO
    Industrial Machinery/Components
    Energy

    Urban One Rebrands Its Iconic Cruise as ONE Voyage Experience, Continues "Party with a Purpose" Legacy with UNCF Partnership

    SILVER SPRING, Md., April 20, 2026 /PRNewswire/ -- Urban One today announced the launch of the ONE Voyage Experience (ONE Voyage), the reimagined evolution of its iconic cruise, as it marks its 25th year of music, culture, and community at sea. The company also announced a new partnership with UNCF (United Negro College Fund), to build on the cruise's tradition of supporting scholarships and critical resources for students attending historically black colleges and universities (HBCUs). Originally introduced as Fantastic Voyage, the cruise became a cultural touchstone through its

    4/20/26 8:30:00 AM ET
    $UONE
    $UONEK
    Broadcasting
    Consumer Discretionary

    AV Appoints Sean Woodward as Chief Financial Officer

      AeroVironment, Inc. ("AV") (NASDAQ:AVAV), a global defense technology leader, today announced the appointment of Sean T. Woodward as Executive Vice President and Chief Financial Officer, effective May 1, 2026. Woodward succeeds Kevin McDonnell, who will be stepping down from the role, as announced earlier this year. McDonnell will remain with the Company in an advisory role through July 2026 to help ensure a smooth transition of responsibilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260412005321/en/Sean Woodward is a seasoned finance leader with more than 22 years of experience in defense technology, including at A

    4/13/26 8:00:00 AM ET
    $AVAV
    Aerospace
    Industrials

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Montrose Environmental Group Inc.

    SC 13G - Montrose Environmental Group, Inc. (0001643615) (Subject)

    12/17/24 4:20:32 PM ET
    $MEG
    Professional Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Fusion Fuel Green PLC

    SC 13G/A - Fusion Fuel Green PLC (0001819794) (Subject)

    12/11/24 4:02:05 PM ET
    $HTOO
    Industrial Machinery/Components
    Energy

    SEC Form SC 13G filed by Sotherly Hotels Inc.

    SC 13G - Sotherly Hotels Inc. (0001301236) (Subject)

    12/9/24 11:56:15 AM ET
    $SOHO
    Real Estate Investment Trusts
    Real Estate

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Breaking: Stock Acquired at INmune Bio Inc. on Jun 26

    Recently, on June 26, 2024, Director Juda Scott bought $36,350 worth of shares (5,000 units at $7.27) (SEC Form 4) in INmune Bio Inc. This insider purchase is significant as it indicates confidence from someone within the company towards its future growth prospects. It's interesting to note that this purchase by Juda Scott follows a series of transactions by other insiders in the company. For example, Moss David J bought $149,993 worth of shares (18,028 units at $8.32) on April 24, 2024, increasing direct ownership by 1% to 1,268,179 units. This demonstrates a consistent trend of insider buying within the organization. Looking back at previous transactions, on May 16, 2024, several key ins

    6/26/24 2:54:12 PM ET
    $INMB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Insider Analysis: Purchase at Gossamer Bio Inc. on Jun 21

    Gossamer Bio Inc. recently witnessed an insider purchase by COO/CFO Bryan Giraudo, who acquired $59,110 worth of shares consisting of 100,000 units at $0.59 per share. Insider purchases like this can provide valuable insights for investors, indicating confidence from individuals within the company about its future prospects. Examining previous insider transactions, on 2024-03-19, insiders Peterson Caryn and Aranda Richard each sold $5,343 worth of shares at $1.33, leading to a decrease in their direct ownership percentages. Similarly, on 2024-03-28, Hasnain Faheem, Giraudo Bryan, and Christian Waage sold shares worth $26,773, $7,431, and $7,430, respectively, impacting their direct ownershi

    6/21/24 3:17:31 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    What Does the Recent Purchase at GlycoMimetics Inc. on Jun 20 Indicate?

    Recently, on June 20, 2024, an insider purchase was made at GlycoMimetics Inc., grabbing the attention of investors. According to the SEC Form 4 filing, SVP Finance, CFO Hahn Brian M. bought $4,335 worth of shares (17,500 units at $0.25), boosting direct ownership by 33% to 70,643 units. Insider transactions are closely monitored by investors as they can provide insights into the company's prospects and the confidence of insiders in the business. Let's delve deeper into the recent insider purchase and analyze any potential patterns or significance in comparison to other insider transactions at GlycoMimetics Inc. In early April 2024, Goldberg Mark Alan was granted 4,584 shares, augmenting di

    6/20/24 6:20:00 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care